Clinical trials
Active, not recruiting Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
220 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2013 | 5 |
| 2014 | 9 |
| 2015 | 7 |
| 2016 | 14 |
| 2017 | 8 |
| 2018 | 11 |
| 2019 | 22 |
| 2020 | 21 |
| 2021 | 32 |
| 2022 | 21 |
| 2023 | 17 |
| 2024 | 24 |
| 2025 | 13 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 220 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 26 |
| M.D. Anderson Cancer Center | 17 |
| Memorial Sloan Kettering Cancer Center | 11 |
| AstraZeneca | 10 |
| CanariaBio Inc. | 4 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 4 |
| University Health Network, Toronto | 4 |
| AbbVie | 3 |
| City of Hope Medical Center | 3 |
| Eli Lilly and Company | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 220 |
| Fallopian Tube Neoplasms | 61 |
| Breast Neoplasms | 43 |
| Endometrial Neoplasms | 38 |
| Carcinoma, Non-Small-Cell Lung | 32 |
| Stomach Neoplasms | 31 |
| Pancreatic Neoplasms | 28 |
| Colorectal Neoplasms | 26 |
| Prostatic Neoplasms | 26 |
| Uterine Cervical Neoplasms | 24 |
Trials
Showing 26 to 50 of 220. Each trial links to its page on Pharma Observatory.
120 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.